Clinical Trial Update: Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating adaptive radiotherapy boost for head and neck squamous cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Squamous Cell Carcinoma, Head and Neck Cancer | Phase 2 | Status: RECRUITING